Lawsuit seeking to overturn FDA decision against prescription drug reimportation waiver dismissed

U.S. District Judge Alexander Williams in Greenbelt, Md., on Tuesday dismissed a lawsuit filed by Montgomery County, Md., that sought to overturn an FDA decision not to approve a waiver for a program to allow county employees to purchase lower-cost prescription drugs from Canada, the AP/Baltimore Sun reports (AP/Baltimore Sun, 8/24).

Last November, the county Council approved a bill that would have required county officials to allow employees to purchase medications from Canada without federal approval.

County Executive Douglas Duncan allowed the bill to take effect without his signature but decided to seek a waiver from FDA rather than implement the program (Kaiser Daily Health Policy Report, 2/24).

FDA rejected the waiver request over concerns about the safety of medications purchased from Canada.

In the lawsuit, filed in February, the county argued that the FDA decision was arbitrary and that federal law allowed such waivers.

However, Williams approved a motion from FDA to dismiss the lawsuit.

He ruled that "FDA's denial of the county's waiver request was mandated by federal law" (AP/Baltimore Sun, 8/24). County Attorney Charles Thompson said that the county will review the decision and will consider an appeal (Marimow, Washington Post, 8/24).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
GLP-1 drugs, like semaglutide, lower risk of hospitalizations for alcohol use disorder